wearable cardioverter defibrillator , WCD (Abkürzung)

In 2001, the FDA approved the LifeVest wearable cardioverter defibrillator.

In November 1986, Heilman, and Larry Bowling founded Lifecor, a company that has developed and now provides the world's first patient wearable cardioverter defibrillator.

The wearable cardioverter defibrillator is an option for patients who are at risk for sudden cardiac arrest (SCA) and are not candidates for or who refuse an implantable defibrillator.

The wearable cardioverter defibrillator (WCD) is worn by patients at risk for sudden cardiac arrest (SCA), allowing their physician time to assess their long-term arrhythmic risk and make appropriate plans.

The HRS SCD Screening Protocol includes a recommendation for consideration of a wearable cardioverter defibrillator as part of the treatment path for patients at risk of SCD.